{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:39:42Z","timestamp":1790962782016,"version":"4.1.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41366-026-02128-w","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:18:11Z","timestamp":1781680691000},"page":"1675-1685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel perspectives on PPAR\u03b3 regulation: from SPPARMs to the emerging role of lncRNAs in metabolic disorders"],"prefix":"10.1038","volume":"50","author":[{"given":"Hao","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuanYuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhua","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8021-3003","authenticated-orcid":false,"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2128_CR1","doi-asserted-by":"crossref","unstructured":"Ng ACT, Delgado V, Borlaug BA, Bax JJ. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol. 2021;18:291\u2013304.","DOI":"10.1038\/s41569-020-00465-5"},{"key":"2128_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/nu17030474","volume":"17","author":"M Maxim","year":"2025","unstructured":"Maxim M, Soroceanu RP, Vl\u0103sceanu VI, Platon RL, Toader M, Miler AA, et al. Dietary habits, obesity, and bariatric surgery: a review of impact and interventions. Nutrients. 2025;17:474.","journal-title":"Nutrients"},{"key":"2128_CR3","doi-asserted-by":"crossref","unstructured":"Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE, et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404:2077\u201393.","DOI":"10.1016\/S0140-6736(24)02317-1"},{"key":"2128_CR4","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.3390\/nu12092722","volume":"12","author":"PL Toi","year":"2020","unstructured":"Toi PL, Anothaisintawee T, Chaikledkaew U, Briones JR, Reutrakul S, Thakkinstian A. Preventive role of diet interventions and dietary factors in type 2 diabetes mellitus: an umbrella review. Nutrients. 2020;12:2722.","journal-title":"Nutrients"},{"key":"2128_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1233906","volume":"14","author":"AKPDL Ribeiro","year":"2023","unstructured":"Ribeiro AKPDL, Carvalho JPR, Bento-Torres NVO. Physical exercise as treatment for adults with type 2 diabetes: a rapid review. Front Endocrinol. 2023;14:1233906.","journal-title":"Front Endocrinol"},{"key":"2128_CR6","doi-asserted-by":"crossref","unstructured":"Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16:545\u201355.","DOI":"10.1038\/s41574-020-0381-5"},{"key":"2128_CR7","doi-asserted-by":"crossref","unstructured":"Sandoval DA, Patti ME. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia. Nat Rev Endocrinol. 2023;19:164\u201376.","DOI":"10.1038\/s41574-022-00757-5"},{"key":"2128_CR8","doi-asserted-by":"crossref","unstructured":"Fink J, Seifert G, Bl\u00fcher M, Fichtner-Feigl S, Marjanovic G. Obesity surgery\u2014weight loss, metabolic changes, oncological effects, and follow-up. Deutsches \u00c4rzteblatt International. 2022;119:70\u201380.","DOI":"10.3238\/arztebl.m2021.0359"},{"key":"2128_CR9","doi-asserted-by":"crossref","unstructured":"Gentileschi P, Bianciardi E, Benavoli D, Campanelli M. Metabolic surgery for type II diabetes: an update. Acta Diabetol. 2021;58:1153\u201359.","DOI":"10.1007\/s00592-021-01722-w"},{"key":"2128_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12951-023-02120-w","volume":"21","author":"C He","year":"2023","unstructured":"He C, Wang K, Xia J, Qian D, Guo J, Zhong L, et al. Natural exosomes-like nanoparticles in mung bean sprouts possesses anti-diabetic effects via activation of PI3K\/Akt\/GLUT4\/GSK-3\u03b2 signaling pathway. J Nanobiotechnol. 2023;21:349.","journal-title":"J Nanobiotechnol"},{"key":"2128_CR11","doi-asserted-by":"crossref","unstructured":"Soccio RE, Chen ER, Lazar MA. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab. 2014;20:573\u201391.","DOI":"10.1016\/j.cmet.2014.08.005"},{"key":"2128_CR12","doi-asserted-by":"crossref","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19:557\u2013566.","DOI":"10.1038\/nm.3159"},{"key":"2128_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","volume":"77","author":"P Tontonoz","year":"2008","unstructured":"Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPAR\u03b3. Annu Rev Biochem. 2008;77:289\u2013312.","journal-title":"Annu Rev Biochem"},{"key":"2128_CR14","doi-asserted-by":"crossref","unstructured":"Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, et al. Structure of the intact PPAR-\u03b3\u2013RXR-\u03b1 nuclear receptor complex on DNA. Nature. 2008;456:350\u2013356.","DOI":"10.1038\/nature07413"},{"key":"2128_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41421-022-00388-0","volume":"8","author":"Z Li","year":"2022","unstructured":"Li Z, Luo L, Yu W, Li P, Ou D, Liu J, et al. PPAR\u03b3 phase separates with RXR\u03b1 at PPREs to regulate target gene expression. Cell Discov. 2022;8:37.","journal-title":"Cell Discov"},{"key":"2128_CR16","doi-asserted-by":"crossref","unstructured":"Hou S, Zhang J, Jiang X, Yang Y, Shan B, Zhang M, et al. PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis. Mol Cell. 2024;84:938\u2013954.e8.","DOI":"10.1016\/j.molcel.2023.12.041"},{"key":"2128_CR17","doi-asserted-by":"crossref","unstructured":"Temple KA, Cohen RN, Wondisford SR, Yu C, Deplewski D, Wondisford FE. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) binding and activation on some ppar response elements. J Biol Chem. 2005;280:3529\u20133540.","DOI":"10.1074\/jbc.M411422200"},{"key":"2128_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cmet.2017.12.002","volume":"27","author":"RK Zwick","year":"2018","unstructured":"Zwick RK, Guerrero-Juarez CF, Horsley V, Plikus MV. Anatomical, physiological, and functional diversity of adipose tissue. Cell Metab. 2018;27:68\u201383.","journal-title":"Cell Metab"},{"key":"2128_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s42255-023-00945-1","volume":"6","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ding X, Wang C, Le Q, Wu D, Song A, et al. Depletion of JunB increases adipocyte thermogenic capacity and ameliorates diet-induced insulin resistance. Nat Metab. 2024;6:78\u201393.","journal-title":"Nat Metab"},{"key":"2128_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tem.2008.09.002","volume":"20","author":"C Christodoulides","year":"2009","unstructured":"Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. Adipogenesis and WNT signalling. Trends Endocrinol Metab. 2009;20:16\u201324.","journal-title":"Trends Endocrinol Metab"},{"key":"2128_CR21","doi-asserted-by":"crossref","unstructured":"MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem. 1995;64:345\u2013373.","DOI":"10.1146\/annurev.bi.64.070195.002021"},{"key":"2128_CR22","doi-asserted-by":"publisher","first-page":"11380","DOI":"10.3390\/ijms252111380","volume":"25","author":"BA Oliveira","year":"2024","unstructured":"Oliveira BA, Levy D, Paz JL, De Freitas FA, Reichert CO, Rodrigues A, et al. 7-Ketocholesterol effects on osteogenic differentiation of adipose tissue-derived mesenchymal stem cells. IJMS. 2024;25:11380.","journal-title":"IJMS"},{"key":"2128_CR23","doi-asserted-by":"crossref","unstructured":"Gupta RK, Mepani RJ, Kleiner S, Lo JC, Khandekar MJ, Cohen P, et al. Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab. 2012;15:230\u2013239.","DOI":"10.1016\/j.cmet.2012.01.010"},{"key":"2128_CR24","doi-asserted-by":"crossref","unstructured":"Shao M, Ishibashi J, Kusminski CM, Wang QA, Hepler C, Vishvanath L, et al. Zfp423 maintains white adipocyte identity through suppression of the beige cell thermogenic gene program. Cell Metab. 2016;23:1167\u20131184.","DOI":"10.1016\/j.cmet.2016.04.023"},{"key":"2128_CR25","doi-asserted-by":"crossref","unstructured":"Del Bosque-Plata L, Mart\u00ednez-Mart\u00ednez E, Espinoza-Camacho M\u00c1, Gragnoli C. The role of TCF7L2 in type 2 diabetes. Diabetes. 2021;70:1220\u20131228.","DOI":"10.2337\/db20-0573"},{"key":"2128_CR26","doi-asserted-by":"crossref","unstructured":"Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145\u2013171.","DOI":"10.1146\/annurev.cellbio.16.1.145"},{"key":"2128_CR27","doi-asserted-by":"crossref","unstructured":"F\u00e8ve B. Adipogenesis: cellular and molecular aspects. Best Pract Res Clin Endocrinol Metab. 2005;19:483\u2013499.","DOI":"10.1016\/j.beem.2005.07.007"},{"key":"2128_CR28","doi-asserted-by":"crossref","unstructured":"Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006;7:885\u2013896.","DOI":"10.1038\/nrm2066"},{"key":"2128_CR29","doi-asserted-by":"crossref","unstructured":"Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem. 2012;81:715\u2013736.","DOI":"10.1146\/annurev-biochem-052110-115718"},{"key":"2128_CR30","doi-asserted-by":"crossref","unstructured":"Chung SS, Lee JS, Kim M, Ahn BY, Jung HS, Lee HM, et al. Regulation of Wnt\/\u03b2-Catenin signaling by CCAAT\/enhancer binding protein \u03b2 during adipogenesis. Obesity. 2012;20:482\u2013487.","DOI":"10.1038\/oby.2011.212"},{"key":"2128_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1072-1","volume":"9","author":"S Park","year":"2018","unstructured":"Park S, Lee M-S, Gwak J, Choi T-I, Lee Y, Ju BG, et al. CCAAT\/enhancer-binding protein-\u03b2 functions as a negative regulator of Wnt\/\u03b2-catenin signaling through activation of AXIN1 gene expression. Cell Death Dis. 2018;9:1023.","journal-title":"Cell Death Dis"},{"key":"2128_CR32","doi-asserted-by":"crossref","unstructured":"Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289:950\u2013953.","DOI":"10.1126\/science.289.5481.950"},{"key":"2128_CR33","doi-asserted-by":"crossref","unstructured":"Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S, et al. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor \u03b3. J Biol Chem. 1996;271:31771\u201331774.","DOI":"10.1074\/jbc.271.50.31771"},{"key":"2128_CR34","doi-asserted-by":"crossref","unstructured":"Tang Q-Q, Gr\u00f8nborg M, Huang H, Kim J-W, Otto TC, Pandey A, et al. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci USA. 2005;102:9766\u20139771.","DOI":"10.1073\/pnas.0503891102"},{"key":"2128_CR35","doi-asserted-by":"crossref","unstructured":"Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829\u2013839.","DOI":"10.1016\/S0092-8674(00)81410-5"},{"key":"2128_CR36","doi-asserted-by":"crossref","unstructured":"Eid JE, Kung AL, Scully R, Livingston DM. p300 Interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell. 2000;102:839\u2013848.","DOI":"10.1016\/S0092-8674(00)00072-6"},{"key":"2128_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","volume":"4","author":"N Kubota","year":"1999","unstructured":"Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4:597\u2013609.","journal-title":"Mol Cell"},{"key":"2128_CR38","doi-asserted-by":"crossref","unstructured":"Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999;4:611\u2013617.","DOI":"10.1016\/S1097-2765(00)80211-7"},{"key":"2128_CR39","doi-asserted-by":"crossref","unstructured":"Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4:585\u2013595.","DOI":"10.1016\/S1097-2765(00)80209-9"},{"key":"2128_CR40","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.3390\/ijms25126498","volume":"25","author":"S Dikalov","year":"2024","unstructured":"Dikalov S, Panov A, Dikalova A. Critical Role of Mitochondrial Fatty Acid Metabolism in Normal Cell Function and Pathological Conditions. IJMS. 2024;25:6498.","journal-title":"IJMS"},{"key":"2128_CR41","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/ijms19051529","volume":"19","author":"L Mar\u00e9chal","year":"2018","unstructured":"Mar\u00e9chal L, Laviolette M, Rodrigue-Way A, Sow B, Brochu M, Caron V, et al. The CD36-PPAR\u03b3 pathway in metabolic disorders. IJMS. 2018;19:1529.","journal-title":"IJMS"},{"key":"2128_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1097-2765(00)80332-9","volume":"4","author":"A Stahl","year":"1999","unstructured":"Stahl A, Hirsch DJ, Gimeno RE, Punreddy S, Ge P, Watson N, et al. Identification of the major intestinal fatty acid transport protein. Mol Cell. 1999;4:299\u2013308.","journal-title":"Mol Cell"},{"key":"2128_CR43","doi-asserted-by":"crossref","unstructured":"Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 1994;79:427\u2013436.","DOI":"10.1016\/0092-8674(94)90252-6"},{"key":"2128_CR44","doi-asserted-by":"crossref","unstructured":"Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte\/macrophage differentiation and uptake of oxidized LDL. Cell. 1998;93:241\u2013252.","DOI":"10.1016\/S0092-8674(00)81575-5"},{"key":"2128_CR45","doi-asserted-by":"crossref","unstructured":"Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami K, Matsuda K, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature. 2013;503:493\u2013499.","DOI":"10.1038\/nature12656"},{"key":"2128_CR46","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.1999.276.1.E1","volume":"276","author":"NB Ruderman","year":"1999","unstructured":"Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol-Endocrinol Metab. 1999;276:E1\u2013E18.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"2128_CR47","doi-asserted-by":"crossref","unstructured":"Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288\u20131295.","DOI":"10.1038\/nm788"},{"key":"2128_CR48","doi-asserted-by":"crossref","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251\u2013262.","DOI":"10.1038\/nrm3311"},{"key":"2128_CR49","doi-asserted-by":"crossref","unstructured":"Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. 2013;123:2764\u20132772.","DOI":"10.1172\/JCI67227"},{"key":"2128_CR50","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799\u2013806.","journal-title":"Nature"},{"key":"2128_CR51","doi-asserted-by":"crossref","unstructured":"Shulman GI. Cellular mechanisms of insulin resistance. J Clin Investig. 2000;106:171\u2013176.","DOI":"10.1172\/JCI10583"},{"key":"2128_CR52","doi-asserted-by":"crossref","unstructured":"Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277:50230\u201350236.","DOI":"10.1074\/jbc.M200958200"},{"key":"2128_CR53","doi-asserted-by":"crossref","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852\u2013871.","DOI":"10.1016\/j.cell.2012.02.017"},{"key":"2128_CR54","doi-asserted-by":"crossref","unstructured":"Satapati S, Sunny NE, Kucejova B, Fu X, He TT, M\u00e9ndez-Lucas A, et al. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res. 2012;53:1080\u20131092.","DOI":"10.1194\/jlr.M023382"},{"key":"2128_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00125-002-1002-7","volume":"46","author":"A Hammarstedt","year":"2003","unstructured":"Hammarstedt A, Smith U. Thiazolidinediones (PPAR\u03b3 ligands) increase IRS-1, UCP-2 and C\/EBP\u03b1 expression, but not transdifferentiation, in L6 muscle cells. Diabetologia. 2003;46:48\u201352.","journal-title":"Diabetologia"},{"key":"2128_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08287-x","volume":"10","author":"J-H Hwang","year":"2019","unstructured":"Hwang J-H, Kim AR, Kim KM, Il Park J, Oh HT, Moon SA, et al. TAZ couples Hippo\/Wnt signalling and insulin sensitivity through Irs1 expression. Nat Commun. 2019;10:421.","journal-title":"Nat Commun"},{"key":"2128_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.carbpol.2019.01.101","volume":"211","author":"H-Y Wang","year":"2019","unstructured":"Wang H-Y, Li Q-M, Yu N-J, Chen W-D, Zha X-Q, Wu D-L, et al. Dendrobium huoshanense polysaccharide regulates hepatic glucose homeostasis and pancreatic \u03b2-cell function in type 2 diabetic mice. Carbohydr Polym. 2019;211:39\u201348.","journal-title":"Carbohydr Polym"},{"key":"2128_CR58","doi-asserted-by":"crossref","unstructured":"Calejman CM, Doxsey WG, Fazakerley DJ, Guertin DA. Integrating adipocyte insulin signaling and metabolism in the multi-omics era. Trends Biochem Sci. 2022;47:531\u2013546.","DOI":"10.1016\/j.tibs.2022.02.009"},{"key":"2128_CR59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-022-00426-x","volume":"8","author":"XK Gao","year":"2022","unstructured":"Gao XK, Rao XS, Cong XX, Sheng ZK, Sun YT, Xu SB, et al. Phase separation of insulin receptor substrate 1 drives the formation of insulin\/IGF-1 signalosomes. Cell Discov. 2022;8:60.","journal-title":"Cell Discov"},{"key":"2128_CR60","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211906","volume":"219","author":"M Quattrocelli","year":"2022","unstructured":"Quattrocelli M, Wintzinger M, Miz K, Panta M, Prabakaran AD, Barish GD, et al. Intermittent prednisone treatment in mice promotes exercise tolerance in obesity through adiponectin. J Exp Med. 2022;219:e20211906.","journal-title":"J Exp Med"},{"key":"2128_CR61","doi-asserted-by":"crossref","unstructured":"Chung SJ, Nagaraju GP, Nagalingam A, Muniraj N, Kuppusamy P, Walker A, et al. ADIPOQ\/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11\/LKB1-mediated activation of the AMPK-ULK1 axis. Autophagy. 2017;13:1386\u20131403.","DOI":"10.1080\/15548627.2017.1332565"},{"key":"2128_CR62","doi-asserted-by":"crossref","unstructured":"Hirayama S, Hori Y, Benedek Z, Suzuki T, Kikuchi K. Fluorogenic probes reveal a role of GLUT4 N-glycosylation in intracellular trafficking. Nat Chem Biol. 2016;12:853\u2013859.","DOI":"10.1038\/nchembio.2156"},{"key":"2128_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56885-9","volume":"16","author":"K Zhang","year":"2025","unstructured":"Zhang K, Gan J, Wang B, Lei W, Zhen D, Yang J, et al. FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice. Nat Commun. 2025;16:1661.","journal-title":"Nat Commun"},{"key":"2128_CR64","doi-asserted-by":"crossref","unstructured":"Wu S, Tan J, Zhang H, Hou D-X, He J. Tissue-specific mechanisms of fat metabolism that focus on insulin actions. J Adv Res. 2023;53:187\u2013198.","DOI":"10.1016\/j.jare.2022.12.009"},{"key":"2128_CR65","doi-asserted-by":"crossref","unstructured":"Neeland IJ, Ross R, Despr\u00e9s J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diab Endocrinol. 2019;7:715\u2013725.","DOI":"10.1016\/S2213-8587(19)30084-1"},{"key":"2128_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pharmthera.2018.11.002","volume":"196","author":"BT Meneguetti","year":"2019","unstructured":"Meneguetti BT, Cardoso MH, Ribeiro CFA, Fel\u00edcio MR, Pinto IB, Santos NC, et al. Neuropeptide receptors as potential pharmacological targets for obesity. Pharm Ther. 2019;196:59\u201378.","journal-title":"Pharm Ther"},{"key":"2128_CR67","first-page":"1083","volume":"5","author":"L Stefanucci","year":"2024","unstructured":"Stefanucci L, Moslemi C, Tom\u00e9 AR, Virtue S, Bidault G, Gleadall NS, et al. SMIM1 absence is associated with reduced energy expenditure and excess weight. Medicines. 2024;5:1083\u2013.e6.","journal-title":"Medicines"},{"key":"2128_CR68","doi-asserted-by":"crossref","unstructured":"Igel LI, Kumar RB, Saunders KH, Aronne LJ. Practical use of pharmacotherapy for obesity. Gastroenterology. 2017;152:1765\u20131779.","DOI":"10.1053\/j.gastro.2016.12.049"},{"key":"2128_CR69","doi-asserted-by":"crossref","unstructured":"Herder C, Kannenberg JM, Huth C, Carstensen-Kirberg M, Rathmann W, Koenig W, et al. Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4\/FF4 Study. Diab Care. 2017;40:569\u2013576.","DOI":"10.2337\/dc16-2259"},{"key":"2128_CR70","doi-asserted-by":"crossref","unstructured":"Pope BD, Warren CR, Parker KK, Cowan CA. Microenvironmental control of adipocyte fate and function. Trends Cell Biol. 2016;26:745\u2013755.","DOI":"10.1016\/j.tcb.2016.05.005"},{"key":"2128_CR71","doi-asserted-by":"crossref","unstructured":"Thomas D, Apovian C. Macrophage functions in lean and obese adipose tissue. Metabolism. 2017;72:120\u2013143.","DOI":"10.1016\/j.metabol.2017.04.005"},{"key":"2128_CR72","doi-asserted-by":"crossref","unstructured":"Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Investig. 2018;128:1538\u20131550.","DOI":"10.1172\/JCI96139"},{"key":"2128_CR73","doi-asserted-by":"crossref","unstructured":"Ying W, Wollam J, Ofrecio JM, Bandyopadhyay G, El Ouarrat D, Lee YS, et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4\/LTB4R1 signaling. J Clin Investig. 2017;127:1019\u20131030.","DOI":"10.1172\/JCI90350"},{"key":"2128_CR74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s11658-024-00559-9","volume":"29","author":"T Hashimoto","year":"2024","unstructured":"Hashimoto T, Hirano K. Effects of mifepristone on adipocyte differentiation in mouse 3T3-L1 cells. Cell Mol Biol Lett. 2024;29:45.","journal-title":"Cell Mol Biol Lett"},{"key":"2128_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127042","volume":"253","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Gan M, Wang X, Liao T, Chen Q, Lei Y, et al. The global perspective on peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in ectopic fat deposition: a review. Int J Biol Macromol. 2023;253:127042.","journal-title":"Int J Biol Macromol"},{"key":"2128_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401931","volume":"11","author":"B Li","year":"2024","unstructured":"Li B, Xia C, He W, Liu J, Duan R, Ji Z, et al. The thyroid hormone analog GC-1 mitigates acute lung injury by inhibiting M1 macrophage polarization. Adv Sci. 2024;11:e2401931.","journal-title":"Adv Sci"},{"key":"2128_CR77","doi-asserted-by":"crossref","unstructured":"Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, et al. Antidiabetic actions of a non-agonist PPAR\u03b3 ligand blocking Cdk5-mediated phosphorylation. Nature. 2011;477:477\u2013481.","DOI":"10.1038\/nature10383"},{"key":"2128_CR78","doi-asserted-by":"crossref","unstructured":"Banks AS, McAllister FE, Camporez JPG, Zushin P-JH, Jurczak MJ, Laznik-Bogoslavski D, et al. An ERK\/Cdk5 axis controls the diabetogenic actions of PPAR\u03b3. Nature. 2015;517:391\u2013395.","DOI":"10.1038\/nature13887"},{"key":"2128_CR79","doi-asserted-by":"crossref","unstructured":"Zhou X, Li J, Wei L, He M, Jia J, Zhang J, et al. Silencing of DsbA-L gene impairs the PPAR\u03b3 agonist function of improving insulin resistance in a high-glucose cell model. J Zhejiang Univ Sci B. 2020;21:990\u2013998.","DOI":"10.1631\/jzus.B2000432"},{"key":"2128_CR80","doi-asserted-by":"crossref","unstructured":"Savarese G, Butler J, Lund LH, Bhatt DL, Anker SD. Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms. Cardiovasc Res. 2022;118:2231\u20132252.","DOI":"10.1093\/cvr\/cvab271"},{"key":"2128_CR81","doi-asserted-by":"crossref","unstructured":"Kraakman MJ, Liu Q, Postigo-Fernandez J, Ji R, Kon N, Larrea D, et al. PPAR\u03b3 deacetylation dissociates thiazolidinedione\u2019s metabolic benefits from its adverse effects. J Clin Investig. 2018;128:2600\u20132612.","DOI":"10.1172\/JCI98709"},{"key":"2128_CR82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/10408444.2017.1351420","volume":"48","author":"MA Davidson","year":"2018","unstructured":"Davidson MA, Mattison DR, Azoulay L, Krewski D. Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Crit Rev Toxicol. 2018;48:52\u2013108.","journal-title":"Crit Rev Toxicol"},{"key":"2128_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30568","volume":"125","author":"G Yang","year":"2024","unstructured":"Yang G, Liu K, Ma S, Qi P. PPAR\u03b3 inhibition promotes osteogenic differentiation of bone marrow mesenchymal stem cells and fracture healing. J Cell Biochem. 2024;125:e30568.","journal-title":"J Cell Biochem"},{"key":"2128_CR84","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/nu13061828","volume":"13","author":"C Pinto","year":"2021","unstructured":"Pinto C, Ib\u00e1\u00f1ez MR, Loyola G, Le\u00f3n L, Salvatore Y, Gonz\u00e1lez C, et al. Characterization of an agarophyton chilense oleoresin containing PPAR\u03b3 natural ligands with insulin-sensitizing effects in a C57Bl\/6J mouse model of diet-induced obesity and antioxidant activity in caenorhabditis elegans. Nutrients. 2021;13:1828.","journal-title":"Nutrients"},{"key":"2128_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.103059","volume":"299","author":"J Yu","year":"2023","unstructured":"Yu J, Hu Y, Sheng M, Gao M, Guo W, Zhang Z, et al. Selective PPAR\u03b3 modulator diosmin improves insulin sensitivity and promotes browning of white fat. J Biol Chem. 2023;299:103059.","journal-title":"J Biol Chem"},{"key":"2128_CR86","doi-asserted-by":"crossref","unstructured":"Weidner C, De Groot JC, Prasad A, Freiwald A, Quedenau C, Kliem M, et al. Amorfrutins are potent antidiabetic dietary natural products. Proc Natl Acad Sci USA. 2012;109:7257\u20137262.","DOI":"10.1073\/pnas.1116971109"},{"key":"2128_CR87","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.3390\/ijms21124415","volume":"21","author":"G Al Haj","year":"2020","unstructured":"Al Haj G, Rey F, Giallongo T, Colli M, Marzani B, Giuliani G, et al. A new selective PPAR\u03b3 modulator inhibits triglycerides accumulation during murine adipocytes\u2019 and human adipose-derived mesenchymal stem cells differentiation. Int J Mol Sci. 2020;21:4415.","journal-title":"Int J Mol Sci"},{"key":"2128_CR88","doi-asserted-by":"crossref","unstructured":"Motani A, Wang Z, Weiszmann J, McGee LR, Lee G, Liu Q, et al. INT131: a selective modulator of PPAR\u03b3. J Mol Biol. 2009;386:1301\u20131311.","DOI":"10.1016\/j.jmb.2009.01.025"},{"key":"2128_CR89","doi-asserted-by":"crossref","unstructured":"Jiang H, Zhou XE, Shi J, Zhou Z, Zhao G, Zhang X, et al. Identification and structural insight of an effective PPAR\u03b3 modulator with improved therapeutic index for anti-diabetic drug discovery. Chem Sci. 2020;11:2260\u20132268.","DOI":"10.1039\/C9SC05487A"},{"key":"2128_CR90","doi-asserted-by":"publisher","first-page":"113653","DOI":"10.1016\/j.biopha.2022.113653","volume":"154","author":"F Chen","year":"2022","unstructured":"Chen F, Ma L, Cai G, Tang J, Wang Y, Liu Q, et al. Identification of a novel PPAR\u03b3 modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation. Biomed Pharmacother. 2022;154:113653.","journal-title":"Biomed Pharmacother"},{"key":"2128_CR91","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-023-01415-6","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li Z, Liu X, Chen X, Zhang S, Chen Y, et al. 3-Hydroxybutyrate ameliorates insulin resistance by inhibiting PPAR\u03b3 Ser273 phosphorylation in type 2 diabetic mice. Sig Transduct Target Ther. 2023;8:190.","journal-title":"Sig Transduct Target Ther"},{"key":"2128_CR92","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang M, Chen J, Li Y, Kuang Z, Dende C, et al. The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9. Science. 2023;381:851\u2013857.","DOI":"10.1126\/science.ade0522"},{"key":"2128_CR93","doi-asserted-by":"crossref","unstructured":"Califf RM. Biomarker definitions and their applications. Exp Biol Med. 2018;243:213\u2013221.","DOI":"10.1177\/1535370217750088"},{"key":"2128_CR94","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12951-025-03146-y","volume":"23","author":"Y Yao","year":"2025","unstructured":"Yao Y, Xu Z, Ding H, Yang S, Chen B, Zhou M, et al. Carrier-free nanoparticles\u2014new strategy of improving druggability of natural products. J Nanobiotechnol. 2025;23:108.","journal-title":"J Nanobiotechnol"},{"key":"2128_CR95","doi-asserted-by":"crossref","unstructured":"Kalliora C, Drosatos K. The glitazars paradox: cardiotoxicity of the metabolically beneficial dual PPAR\u03b1 and PPAR\u03b3 activation. J Cardiovasc Pharmacol. 2020;76:514\u2013526.","DOI":"10.1097\/FJC.0000000000000891"},{"key":"2128_CR96","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","volume":"92","author":"L Wang","year":"2014","unstructured":"Wang L, Waltenberger B, Pferschy-Wenzig E-M, Blunder M, Liu X, Malainer C, et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): a review. Biochem Pharmacol. 2014;92:73\u201389.","journal-title":"Biochem Pharmacol"},{"key":"2128_CR97","doi-asserted-by":"crossref","unstructured":"Alterman JF, Godinho BMDC, Hassler MR, Ferguson CM, Echeverria D, Sapp E, et al. A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system. Nat Biotechnol. 2019;37:884\u2013894.","DOI":"10.1038\/s41587-019-0205-0"},{"key":"2128_CR98","doi-asserted-by":"crossref","unstructured":"Kulkarni JA, Witzigmann D, Chen S, Cullis PR, Van Der Meel R. Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Acc Chem Res. 2019;52:2435\u20132444.","DOI":"10.1021\/acs.accounts.9b00368"},{"key":"2128_CR99","doi-asserted-by":"crossref","unstructured":"Nair JK, Attarwala H, Sehgal A, Wang Q, Aluri K, Zhang X, et al. Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc\u2013siRNA conjugates. Nucleic Acids Res. 2017;45:10969\u201310977.","DOI":"10.1093\/nar\/gkx818"},{"key":"2128_CR100","doi-asserted-by":"crossref","unstructured":"Kumar V, Turnbull WB. Targeted delivery of oligonucleotides using multivalent protein\u2013carbohydrate interactions. Chem Soc Rev. 2023;52:1273\u20131287.","DOI":"10.1039\/D2CS00788F"},{"key":"2128_CR101","doi-asserted-by":"crossref","unstructured":"Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, et al. International union of pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev. 2006;58:726\u2013741.","DOI":"10.1124\/pr.58.4.5"},{"key":"2128_CR102","doi-asserted-by":"crossref","unstructured":"Arifi S, Marschner JA, Pollinger J, Isigkeit L, Heitel P, Kaiser A, et al. Targeting the alternative vitamin E metabolite binding site enables noncanonical PPAR\u03b3 modulation. J Am Chem Soc. 2023;145:14802\u201314810.","DOI":"10.1021\/jacs.3c03417"},{"key":"2128_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4898","volume":"33","author":"NE Banayan","year":"2024","unstructured":"Banayan NE, Loughlin BJ, Singh S, Forouhar F, Lu G, Wong K-H, et al. Systematic enhancement of protein crystallization efficiency by bulk lysine-to-arginine (KR) substitution. Protein Sci. 2024;33:e4898.","journal-title":"Protein Sci"},{"key":"2128_CR104","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-bioeng-060418-052453","volume":"21","author":"J Ognjenovi\u0107","year":"2019","unstructured":"Ognjenovi\u0107 J, Grisshammer R, Subramaniam S. Frontiers in cryo electron microscopy of complex macromolecular assemblies. Annu Rev Biomed Eng. 2019;21:395\u2013415.","journal-title":"Annu Rev Biomed Eng"},{"key":"2128_CR105","doi-asserted-by":"crossref","unstructured":"Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, et al. PPAR\u03b3 and C\/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008;22:2941\u20132952.","DOI":"10.1101\/gad.1709008"},{"key":"2128_CR106","doi-asserted-by":"crossref","unstructured":"Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science. 2009;324:407\u201310.","DOI":"10.1126\/science.1164265"},{"key":"2128_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52146-3","volume":"15","author":"A Comajuncosa-Creus","year":"2024","unstructured":"Comajuncosa-Creus A, Jorba G, Barril X, Aloy P. Comprehensive detection and characterization of human druggable pockets through binding site descriptors. Nat Commun. 2024;15:7917.","journal-title":"Nat Commun"},{"key":"2128_CR108","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez S, Alice JI, Bellera CL, Talevi A. Structure-based binding pocket detection and druggability assessment. In: Scotti MT, Bellera CL, editors. Drug target selection and validation. Springer International Publishing; 2022. pp 83\u201397.","DOI":"10.1007\/978-3-030-95895-4_5"},{"key":"2128_CR109","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1016\/j.bpj.2022.08.015","volume":"121","author":"D Ghoshdastidar","year":"2022","unstructured":"Ghoshdastidar D, Bansal M. Flexibility of flanking DNA is a key determinant of transcription factor affinity for the core motif. Biophys J. 2022;121:3987\u20134000.","journal-title":"Biophys J"},{"key":"2128_CR110","doi-asserted-by":"crossref","unstructured":"Kung J, Henry RR. Thiazolidinedione safety. Expert Opin Drug Saf. 2012;11:565\u201379.","DOI":"10.1517\/14740338.2012.691963"},{"key":"2128_CR111","doi-asserted-by":"crossref","unstructured":"Chusacultanachai S, Glenn KA, Rodriguez AO, Read EK, Gardner JF, Katzenellenbogen BS, et al. Analysis of estrogen response element binding by genetically selected steroid receptor dna binding domain mutants exhibiting altered specificity and enhanced affinity. J Biol Chem. 1999;274:23591\u201323598.","DOI":"10.1074\/jbc.274.33.23591"},{"key":"2128_CR112","doi-asserted-by":"crossref","unstructured":"Buechel ER, Pinkett HW. Activity of the pleiotropic drug resistance transcription factors Pdr1p and Pdr3p is modulated by binding site flanking sequences. FEBS Lett. 2024;598:169\u2013186.","DOI":"10.1002\/1873-3468.14762"},{"key":"2128_CR113","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-024-03154-0","volume":"43","author":"J Shan","year":"2024","unstructured":"Shan J, Li X, Sun R, Yao Y, Sun Y, Kuang Q, et al. Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPAR\u03b3-driven lipid biosynthesis via regulating lipidome metabolic reprogramming. J Exp Clin Cancer Res. 2024;43:227.","journal-title":"J Exp Clin Cancer Res"},{"key":"2128_CR114","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1158\/0008-5472.CAN-06-3043","volume":"67","author":"H-J Kim","year":"2007","unstructured":"Kim H-J, Kim J-Y, Meng Z, Wang LH, Liu F, Conrads TP, et al. 15-Deoxy-\u039412,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-\u03b1 via covalent modification of DNA-Binding Domain. Cancer Res. 2007;67:2595\u2013602.","journal-title":"Cancer Res"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02128-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02128-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02128-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:24:20Z","timestamp":1786465460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02128-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":114,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2128"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02128-w","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}